Tribute is a pharmaceutical company with a focus on the acquisition, licensing, development and promotion of healthcare products in canada.
Business Model:
Revenue: $75.3M
Employees: 11-50
Tribute Pharmaceuticals Canada Inc. was acquired by
Nuvo Research.
The acquisition happend on 2018-08-10.
Details of the transaction were not public
Address: 9038468 U.S. Headquarters 400 Alexander Park
City:
State: NJ
Zip: 08540
Country: US
Tribute is a pharmaceutical company with a focus on the acquisition, licensing, development and promotion of healthcare products in canada.
Contact Phone:
+19058761118
Contact Email:
Listed Exchange:
CSE
IPO Date:
12/1/2000
Ticker Symbol:
TBUFF
IPO Price:
$0.7/share
Amount Raised:
$28M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2014 | Post-IPO Equity | 2 | $27.9M |
Dundee Corporation Mackie Research Capital Corporation Mackie Research Capital Corporation Dundee Corporation |
8/2013 | Post-IPO Debt | $6M | 6/2015 | Post-IPO Equity | $4.1M |
---|
Announced Date | Name | Price |
---|---|---|
6/2015 | Medical Futures |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|